| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2159410 | Radiotherapy and Oncology | 2010 | 7 Pages |
PurposeEarly assessment of radiotherapy (RT) quality in the ongoing EORTC trial comparing primary temozolomide versus RT in low-grade gliomas.Materials and methodsRT plans provided for dummy cases were evaluated and compared against expert plans. We analysed: (1) tumour and organs-at-risk delineation, (2) geometric and dosimetric characteristics, (3) planning parameters, compliance with dose prescription and Dmax for OAR (4) indices: RTOG conformity index (CI), coverage factor (CF), tissue protection factor (PF); conformity number (CN = PF × CF); dose homogeneity in PTV (U).ResultsForty-one RT plans were evaluated. Only two (5%) centres were requested to repeat CTV–PTV delineations. Three (7%) plans had a significant under-dosage and dose homogeneity in one deviated >10%. Dose distribution was good with mean values of 1.5, 1, 0.68, and 0.68 (ideal values = 1) for CI, CF, PF, and CN, respectively. CI and CN strongly correlated with PF and they correlated with PTV. Planning with more beams seems to increase PTVDmin, improving CF. U correlated with PTVDmax.ConclusionPreliminary results of the dummy run procedure indicate that most centres conformed to protocol requirements. To quantify plan quality we recommend systematic calculation of U and either CI or CN, both of which measure the amount of irradiated normal brain tissue.
